Education
About Us
Working with TipRanks
Follow Us
Emcure Pharmaceuticals Limited (IN:EMCURE)
:EMCURE
Summary of all the Indicators
Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Emcure Pharmaceuticals Limited’s (EMCURE) Moving Averages Convergence Divergence (MACD) indicator is 33.77, suggesting Emcure Pharmaceuticals Limited is a Sell.
Emcure Pharmaceuticals Limited’s (EMCURE) 20-Day exponential moving average is 1448.89, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹1,345.35, making it a Buy.
Emcure Pharmaceuticals Limited’s (EMCURE) 50-Day exponential moving average is 1413.52, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹1,345.35, making it a Buy.
Emcure Pharmaceuticals Limited (EMCURE) Pivot Points
Classic
1,458.37
1,485.53
1,503.77
1,530.93
1,549.17
1,576.33
1,594.57
Fibonacci
1,485.53
1,502.88
1,513.59
1,530.93
1,548.28
1,558.99
1,576.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Emcure Pharmaceuticals Limited (EMCURE) Moving Averages
MA5
1,521.66Buy
1,512.16Buy
MA10
1,460.32Buy
1,480.56Buy
MA20
1,431.57Buy
1,448.89Buy
MA50
1,400.68Buy
1,413.52Buy
MA100
1,387.60Buy
1,381.22Buy
MA200
1,304.88Buy
1,301.37Buy
Emcure Pharmaceuticals Limited’s (EMCURE) 10-Day exponential moving average is 1480.56, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹1,345.35, making it a Buy.
Emcure Pharmaceuticals Limited’s (EMCURE) 100-Day exponential moving average is 1381.22, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹1,345.35, making it a Buy.
Emcure Pharmaceuticals Limited’s (EMCURE) stock price is ₹1,345.35 and Emcure Pharmaceuticals Limited’s (EMCURE) 50-day simple moving average is 1400.68, creating a Buy signal.
Emcure Pharmaceuticals Limited’s (EMCURE) stock price is ₹1,345.35 and Emcure Pharmaceuticals Limited’s (EMCURE) 100-day simple moving average is 1387.60, creating a Buy signal.
Emcure Pharmaceuticals Limited’s (EMCURE) stock price is ₹1,345.35 and Emcure Pharmaceuticals Limited’s (EMCURE) 200-day simple moving average is 1304.88, creating a Buy signal.
Emcure Pharmaceuticals Limited (EMCURE) Technical Indicators
RSI (14)
68.59
Neutral
STOCH (9,6)
82.01
Sell
STOCHRSI (14)
82.01
Sell
MACD (12,26)
33.77
Sell
ADX (14)
43.34
Neutral
Williams %R
-13.14
Sell
CCI (14)
145.83
Sell
ATR (14)
47.77
-
Ultimate Oscillator
60.20
Neutral
ROC
11.17
Buy
Emcure Pharmaceuticals Limited’s (EMCURE) Relative Strength Index (RSI) is 68.59, creating a Neutral signal.
Emcure Pharmaceuticals Limited’s (EMCURE) Trend Strength Indicator (ADX) is 43.34, creating a Neutral signal.
Emcure Pharmaceuticals Limited’s (EMCURE) Commodity Channel Index (CCI) is 145.83, creating a Sell signal.
Emcure Pharmaceuticals Limited’s (EMCURE) Price Rate of Change (ROC) is 11.17, creating a Buy signal.
FAQ
Is EMCURE a Buy, Hold, or Sell?
Based on EMCURE’s technical indicators, EMCURE is a Buy.
What is EMCURE’s RSI (14)?
EMCURE’s RSI (14) is 68.59, which suggests EMCURE is a Neutral.
What is EMCURE’s MACD?
EMCURE’s MACD is 33.77, which suggests EMCURE is a Sell.
What is EMCURE’s 5-day moving average?
EMCURE’s 5-day moving average is 1521.66, which suggests EMCURE is a Buy.
What is EMCURE’s 20-day moving average?
EMCURE 20-day moving average is 1431.57, which suggests EMCURE is a Buy.
What is EMCURE’s 50-day moving average?
EMCURE’s 50-day moving average is 1400.68, which suggests EMCURE is a Buy.
What is EMCURE’s 200-day moving average?
EMCURE’s 200-day moving average is 1304.88, which suggests EMCURE is a Buy.
What is EMCURE’s Williams % R (14)?
EMCURE’s Williams % R (14) is -13.14, which suggests EMCURE is a Sell.
What is EMCURE’s CCI (14)?
EMCURE’s CCI (14) is 145.83, which suggests EMCURE is a Sell.
What is the share price of Emcure Pharmaceuticals Limited?